{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T22:01:49Z","timestamp":1792533709992,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/aps.2018.37","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T06:03:29Z","timestamp":1526537009000},"page":"1155-1163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis"],"prefix":"10.1038","volume":"39","author":[{"given":"Xiao-dong","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon T","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyuan","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"103_CR1","first-page":"43","volume":"59","author":"AS Mullasari","year":"2011","unstructured":"Mullasari AS, Balaji P, Khando T. Managing complications in acute myocardial infarction. J Assoc Physicians India 2011; 59: 43\u20138.","journal-title":"J Assoc Physicians India"},{"key":"103_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1172\/JCI62874","volume":"123","author":"DJ Hausenloy","year":"2013","unstructured":"Hausenloy DJ, Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest 2013; 123: 92\u2013100.","journal-title":"J Clin Invest"},{"key":"103_CR3","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095\u2013128.","journal-title":"Lancet"},{"key":"103_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF03194597","volume":"47","author":"A Chmurzynska","year":"2006","unstructured":"Chmurzynska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 2006; 47: 39\u201348.","journal-title":"J Appl Genet"},{"key":"103_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0005-2760(88)90141-5","volume":"961","author":"JF Glatz","year":"1988","unstructured":"Glatz JF, van Bilsen M, Paulussen RJ, Veerkamp JH, van der Vusse GJ, Reneman RS. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 1988; 961: 148\u201352.","journal-title":"Biochim Biophys Acta"},{"key":"103_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ijcard.2006.09.003","volume":"119","author":"P Ecollan","year":"2007","unstructured":"Ecollan P, Collet JP, Boon G, Tanguy ML, Fievet ML, Haas R, et al. Pre-hospital detection of acute myocardial infarction with ultra-rapid human fatty acid-binding protein (H-FABP) immunoassay. Int J Cardiol 2007; 119: 349\u201354.","journal-title":"Int J Cardiol"},{"key":"103_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1042\/CS20100435","volume":"121","author":"Z Huang","year":"2011","unstructured":"Huang Z, Zhong X, Irwin MG, Ji S, Wong GT, Liu Y, et al. Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients. Clin Sci (Lond) 2011; 121: 57\u201369.","journal-title":"Clin Sci (Lond)"},{"key":"103_CR8","doi-asserted-by":"crossref","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1459\u2013544.","DOI":"10.1016\/S0140-6736(16)31012-1"},{"key":"103_CR9","first-page":"317","volume":"65","author":"E Puymirat","year":"2015","unstructured":"Puymirat E. Epidemiology of coronary artery disease. Rev Prat 2015; 65: 317\u201320.","journal-title":"Rev Prat"},{"key":"103_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ahj.2003.11.027","volume":"148","author":"K Okrainec","year":"2004","unstructured":"Okrainec K, Banerjee DK, Eisenberg MJ. Coronary artery disease in the developing world. Am Heart J 2004; 148: 7\u201315.","journal-title":"Am Heart J"},{"key":"103_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6","volume":"190","author":"DL Carden","year":"2000","unstructured":"Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol 2000; 190: 255\u201366.","journal-title":"J Pathol"},{"key":"103_CR12","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1016\/j.jtcvs.2013.02.016","volume":"145","author":"W Oosterlinck","year":"2013","unstructured":"Oosterlinck W, Dresselaers T, Geldhof V, Nevelsteen I, Janssens S, Himmelreich U, et al. Diabetes mellitus and the metabolic syndrome do not abolish, but might reduce, the cardioprotective effect of ischemic postconditioning. J Thorac Cardiovasc Surg 2013; 145: 1595\u2013602.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"103_CR13","doi-asserted-by":"publisher","first-page":"198048","DOI":"10.1155\/2012\/198048","volume":"2012","author":"X Yin","year":"2012","unstructured":"Yin X, Zheng Y, Zhai X, Zhao X, Cai L. Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia\/reperfusion injury. Exp Diabetes Res 2012; 2012: 198048.","journal-title":"Exp Diabetes Res"},{"key":"103_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2015.12.020","volume":"91","author":"A Lejay","year":"2016","unstructured":"Lejay A, Fang F, John R, Van JA, Barr M, Thaveau F, et al. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus. J Mol Cell Cardiol 2016; 91: 11\u201322.","journal-title":"J Mol Cell Cardiol"},{"key":"103_CR15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.2337\/db15-0782","volume":"65","author":"H Li","year":"2016","unstructured":"Li H, Yao W, Liu Z, Xu A, Huang Y, Ma XL, et al. Hyperglycemia abrogates ischemic postconditioning cardioprotection by impairing AdipoR1\/Caveolin-3\/STAT3 signaling in diabetic rats. Diabetes 2016; 65: 942\u201355.","journal-title":"Diabetes"},{"key":"103_CR16","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1242\/jeb.01172","volume":"207","author":"GA Ordway","year":"2004","unstructured":"Ordway GA, Garry DJ. Myoglobin: an essential hemoprotein in striated muscle. J Exp Biol 2004; 207: 3441\u20136.","journal-title":"J Exp Biol"},{"key":"103_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00019501-199910001-00003","volume":"10","author":"FS Apple","year":"1999","unstructured":"Apple FS. Creatine kinase isoforms and myoglobin: early detection of myocardial infarction and reperfusion. Coron Artery Dis 1999; 10: 75\u20139.","journal-title":"Coron Artery Dis"},{"key":"103_CR18","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.12659\/MSM.890909","volume":"20","author":"S Wang","year":"2014","unstructured":"Wang S, Qin L, Wu T, Deng B, Sun Y, Hu D, et al. Elevated cardiac markers in chronic kidney disease as a consequence of hyperphosphatemia-induced cardiac myocyte injury. Med Sci Monit 2014; 20: 2043\u201353.","journal-title":"Med Sci Monit"},{"key":"103_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0009-8981(99)00261-2","volume":"294","author":"JR Beuerle","year":"2000","unstructured":"Beuerle JR, Azzazy HM, Styba G, Duh SH, Christenson RH. Characteristics of myoglobin, carbonic anhydrase III and the myoglobin\/carbonic anhydrase III ratio in trauma, exercise, and myocardial infarction patients. Clin Chim Acta 2000; 294: 115\u201328.","journal-title":"Clin Chim Acta"},{"key":"103_CR20","first-page":"5","volume":"28","author":"JM Tanasijevic","year":"2007","unstructured":"Tanasijevic JM. Non-invasive assessment of coronary artery patency after thrombolysis using serum myoglobin measurements. Prilozi 2007; 28: 5\u201311.","journal-title":"Prilozi"},{"key":"103_CR21","first-page":"493","volume":"27","author":"C Roych","year":"1982","unstructured":"Roych C, Magioncalda A, Sanfelici D, Mattiauda C, Cavazzana C, Mellini M, et al. Diagnostic and prognostic value of radioimmunologic determination of myoglobin in myocardial infarction. Cardiologia 1982; 27: 493\u20136.","journal-title":"Cardiologia"},{"key":"103_CR22","first-page":"145","volume":"(3)","author":"A Tashmatova","year":"1986","unstructured":"Tashmatova A, Staroverov, II, Titov VN, Ruda M. Blood myoglobin in the diagnosis and prognosis of acute myocardial infarct. Lab Delo 1986; (3): 145\u20139.","journal-title":"Lab Delo"},{"key":"103_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/03009738309178454","volume":"88","author":"P Venge","year":"1983","unstructured":"Venge P. The diagnostic and prognostic value of serum-myoglobin determinations in acute myocardial infarction. Ups J Med Sci 1983; 88: 205\u201311.","journal-title":"Ups J Med Sci"},{"key":"103_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.ahj.2009.06.011","volume":"158","author":"SR Wilson","year":"2009","unstructured":"Wilson SR, Sabatine MS, Braunwald E, Sloan S, Murphy SA, Morrow DA. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial. Am Heart J 2009; 158: 386\u201391.","journal-title":"Am Heart J"},{"key":"103_CR25","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/clc.4960220107","volume":"22","author":"MJ Tanasijevic","year":"1999","unstructured":"Tanasijevic MJ, Cannon CP, Antman EM. The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery disease. Clin Cardiol 1999; 22: 13\u20136.","journal-title":"Clin Cardiol"},{"key":"103_CR26","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s40291-012-0011-6","volume":"16","author":"RP Tiwari","year":"2012","unstructured":"Tiwari RP, Jain A, Khan Z, Kohli V, Bharmal RN, Kartikeyan S, et al. Cardiac troponins I and T: molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction. Mol Diagn Ther 2012; 16: 371\u201381.","journal-title":"Mol Diagn Ther"},{"key":"103_CR27","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/heartjnl-2014-305533","volume":"100","author":"PK Myint","year":"2014","unstructured":"Myint PK, Kwok CS, Bachmann MO, Stirling S, Shepstone L, Zaman MJ. Prognostic value of troponins in acute coronary syndrome depends upon patient age. Heart 2014; 100: 1583\u201390.","journal-title":"Heart"},{"key":"103_CR28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/imj.12642","volume":"45","author":"WJ Li","year":"2015","unstructured":"Li WJ, Chen XM, Nie XY, Lin XX, Cheng YJ, Hu CH, et al. Early diagnostic and prognostic utility of high-sensitive troponin assays in acute myocardial infarction: a meta-analysis. Intern Med J 2015; 45: 748\u201356.","journal-title":"Intern Med J"},{"key":"103_CR29","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0002-9149(98)00490-1","volume":"82","author":"H Benamer","year":"1998","unstructured":"Benamer H, Steg PG, Benessiano J, Vicaut E, Gaultier CJ, Boccara A, et al. Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris. Am J Cardiol 1998; 82: 845\u201350.","journal-title":"Am J Cardiol"},{"key":"103_CR30","first-page":"71","volume":"11","author":"P Grande","year":"1980","unstructured":"Grande P, Naestoft J, Christiansen C. An easy and reliable estimation of acute myocardial infarct size from serum CK-MB measurements. Eur J Cardiol 1980; 11: 71\u20137.","journal-title":"Eur J Cardiol"},{"key":"103_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0167-5273(83)90149-3","volume":"2","author":"R Roberts","year":"1983","unstructured":"Roberts R, Ambos HD, Sobel BE. Estimation of infarct size with MB rather than total CK. Int J Cardiol 1983; 2: 479\u201392.","journal-title":"Int J Cardiol"},{"key":"103_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/MCA.0b013e32834e4f8f","volume":"23","author":"JS Mills","year":"2012","unstructured":"Mills JS, Mahaffey KW, Lokhnygina Y, Nicolau JC, Ruzyllo W, Adams PX, et al. Prediction of enzymatic infarct size in ST-segment elevation myocardial infarction. Coron Artery Dis 2012; 23: 118\u201325.","journal-title":"Coron Artery Dis"},{"key":"103_CR33","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.amjcard.2014.12.008","volume":"115","author":"T Dohi","year":"2015","unstructured":"Dohi T, Maehara A, Brener SJ, Genereux P, Gershlick AH, Mehran R, et al. Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial). Am J Cardiol 2015; 115: 563\u201370.","journal-title":"Am J Cardiol"},{"key":"103_CR34","doi-asserted-by":"publisher","first-page":"CR474","DOI":"10.12659\/MSM.881932","volume":"17","author":"Y Luo","year":"2011","unstructured":"Luo Y, Pan YZ, Zeng C, Li GL, Lei XM, Liu Z, et al. Altered serum creatine kinase level and cardiac function in ischemia-reperfusion injury during percutaneous coronary intervention. Med Sci Monit 2011; 17: CR474\u20139.","journal-title":"Med Sci Monit"},{"key":"103_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/14017431.2014.923930","volume":"48","author":"FE Holmberg","year":"2014","unstructured":"Holmberg FE, Ottas KA, Andreasen C, Perko MJ, Moller CH, Engstrom T, et al. Conditioning techniques and ischemic reperfusion injury in relation to on-pump cardiac surgery. Scand Cardiovasc J 2014; 48: 241\u20138.","journal-title":"Scand Cardiovasc J"},{"key":"103_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ahj.2014.06.008","volume":"168","author":"A Bagai","year":"2014","unstructured":"Bagai A, Schulte PJ, Granger CB, Mahaffey KW, Christenson RH, Bell G, et al. Prognostic implications of creatine kinase-MB measurements in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention. Am Heart J 2014; 168: 503\u201311.e2.","journal-title":"Am Heart J"},{"key":"103_CR37","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1745-6215-14-123","volume":"14","author":"RD Lopes","year":"2013","unstructured":"Lopes RD, Lokhnygina Y, Hasselblad V, Newby KL, Yow E, Granger CB, et al. Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy. Trials 2013; 14: 123.","journal-title":"Trials"},{"key":"103_CR38","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.ahj.2012.07.018","volume":"164","author":"MJ Domanski","year":"2012","unstructured":"Domanski MJ. Prognostic implications of troponin T and creatine kinase-MB elevation after coronary artery bypass grafting. Am Heart J 2012; 164: 636\u20137.","journal-title":"Am Heart J"},{"key":"103_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1258\/000456302760042155","volume":"39","author":"SM Saadeddin","year":"2002","unstructured":"Saadeddin SM, Habbab MA, Sobki SH, Ferns GA. Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: clinical outcome. Ann Clin Biochem 2002; 39: 392\u20137.","journal-title":"Ann Clin Biochem"},{"key":"103_CR40","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1258\/0004563001900075","volume":"37","author":"BM Harris","year":"2000","unstructured":"Harris BM, Nageh T, Marsden JT, Thomas MR, Sherwood RA. Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures. Ann Clin Biochem 2000; 37: 764\u20139.","journal-title":"Ann Clin Biochem"},{"key":"103_CR41","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.1161\/CIRCULATIONAHA.114.010614","volume":"130","author":"KH Melamed","year":"2014","unstructured":"Melamed KH, Goldhaber SZ. Cardiology Patient Page: inflammation and myocardial infarction. Circulation 2014; 130: e334\u20136.","journal-title":"Circulation"},{"key":"103_CR42","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1536\/jhj.43.607","volume":"43","author":"J Auer","year":"2002","unstructured":"Auer J, Berent R, Lassnig E, Eber B. C-reactive protein and coronary artery disease. Jpn Heart J 2002; 43: 607\u201319.","journal-title":"Jpn Heart J"},{"key":"103_CR43","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0140-6736(96)07591-5","volume":"349","author":"F Haverkate","year":"1997","unstructured":"Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349: 462\u20136.","journal-title":"Lancet"},{"key":"103_CR44","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ijcard.2011.11.004","volume":"166","author":"AN Mather","year":"2013","unstructured":"Mather AN, Fairbairn TA, Artis NJ, Greenwood JP, Plein S. Relationship of cardiac biomarkers and reversible and irreversible myocardial injury following acute myocardial infarction as determined by cardiovascular magnetic resonance. Int J Cardiol 2013; 166: 458\u201364.","journal-title":"Int J Cardiol"},{"key":"103_CR45","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3892\/br.2016.793","volume":"5","author":"D Liu","year":"2016","unstructured":"Liu D, Qi X, Li Q, Jia W, Wei L, Huang A, et al. Increased complements and high-sensitivity C-reactive protein predict heart failure in acute myocardial infarction. Biomed Rep 2016; 5: 761\u20135.","journal-title":"Biomed Rep"},{"key":"103_CR46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF00240061","volume":"160\u20131","author":"EG Krause","year":"1996","unstructured":"Krause EG, Rabitzsch G, Noll F, Mair J, Puschendorf B. Glycogen phosphorylase isoenzyme BB in diagnosis of myocardial ischaemic injury and infarction. Mol Cell Biochem 1996; 160\u20131: 289\u201395.","journal-title":"Mol Cell Biochem"},{"key":"103_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408369709038215","volume":"34","author":"J Mair","year":"1997","unstructured":"Mair J. Progress in myocardial damage detection: new biochemical markers for clinicians. Crit Rev Clin Lab Sci 1997; 34: 1\u201366.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"103_CR48","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/clinchem\/41.7.966","volume":"41","author":"G Rabitzsch","year":"1995","unstructured":"Rabitzsch G, Mair J, Lechleitner P, Noll F, Hofmann U, Krause EG, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem 1995; 41: 966\u201378.","journal-title":"Clin Chem"},{"key":"103_CR49","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.clinbiochem.2007.07.018","volume":"40","author":"MM Mion","year":"2007","unstructured":"Mion MM, Novello E, Altinier S, Rocco S, Zaninotto M, Plebani M. Analytical and clinical performance of a fully automated cardiac multi-markers strategy based on protein biochip microarray technology. Clin Biochem 2007; 40: 1245\u201351.","journal-title":"Clin Biochem"},{"key":"103_CR50","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1093\/eurheartj\/ehn363","volume":"29","author":"CJ McCann","year":"2008","unstructured":"McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J 2008; 29: 2843\u201350.","journal-title":"Eur Heart J"},{"key":"103_CR51","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1001\/jama.2011.1896","volume":"306","author":"T Keller","year":"2011","unstructured":"Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011; 306: 2684\u201393.","journal-title":"JAMA"},{"key":"103_CR52","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.amjcard.2012.06.020","volume":"110","author":"L Lillpopp","year":"2012","unstructured":"Lillpopp L, Tzikas S, Ojeda F, Zeller T, Baldus S, Bickel C, et al. Prognostic information of glycogen phosphorylase isoenzyme BB in patients with suspected acute coronary syndrome. Am J Cardiol 2012; 110: 1225\u201330.","journal-title":"Am J Cardiol"},{"key":"103_CR53","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1056\/NEJMoa0900428","volume":"361","author":"T Reichlin","year":"2009","unstructured":"Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009; 361: 858\u201367.","journal-title":"N Engl J Med"},{"key":"103_CR54","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1373\/clinchem.2009.132654","volume":"56","author":"E Giannitsis","year":"2010","unstructured":"Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010; 56: 254\u201361.","journal-title":"Clin Chem"},{"key":"103_CR55","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1016\/j.ijcard.2013.05.015","volume":"168","author":"JA Giner-Caro","year":"2013","unstructured":"Giner-Caro JA, Caballero L, Casas-Pina T, Pastor-Perez F, Garrido-Bravo IP, Sanchez-Mas J, et al. High sensitive cardiac troponin T in the management of uncertain chest pain. Int J Cardiol 2013; 168: 4422\u20133.","journal-title":"Int J Cardiol"},{"key":"103_CR56","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.ahj.2011.02.021","volume":"161","author":"A Durante","year":"2011","unstructured":"Durante A. The value of elevated high-sensitive troponin T. Am Heart J 2011; 161: e33.","journal-title":"Am Heart J"},{"key":"103_CR57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.amjmed.2011.10.031","volume":"125","author":"A Irfan","year":"2012","unstructured":"Irfan A, Twerenbold R, Reiter M, Reichlin T, Stelzig C, Freese M, et al. Determinants of high-sensitivity troponin T among patients with a noncardiac cause of chest pain. Am J Med 2012; 125: 491\u20138.e1.","journal-title":"Am J Med"},{"key":"103_CR58","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ahj.2010.09.018","volume":"161","author":"G Ndrepepa","year":"2011","unstructured":"Ndrepepa G, Braun S, Mehilli J, Birkmeier KA, Byrne RA, Ott I, et al. Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin. Am Heart J 2011; 161: 68\u201375.","journal-title":"Am Heart J"},{"key":"103_CR59","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.amjmed.2012.07.015","volume":"125","author":"T Reichlin","year":"2012","unstructured":"Reichlin T, Twerenbold R, Reiter M, Steuer S, Bassetti S, Balmelli C, et al. Introduction of high-sensitivity troponin assays: impact on myocardial infarction incidence and prognosis. Am J Med 2012; 125: 1205\u201313.e1.","journal-title":"Am J Med"},{"key":"103_CR60","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2261-14-77","volume":"14","author":"A Vaidya","year":"2014","unstructured":"Vaidya A, Severens JL, Bongaerts BW, Cleutjens KB, Nelemans PJ, Hofstra L, et al. High-sensitive troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation. BMC Cardiovasc Disord 2014; 14: 77.","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"103_CR61","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/aps.2017.167","volume":"39","author":"Peter Jirak","year":"2017","unstructured":"Jirak P, Fejzic D, Paar V, Wernly B, Pistulli R, Rohm I, et al. Influences of Ivabradine treatment on serum levels of cardiac biomarkers sST2, GDF-15, suPAR and H-FABP in patients with chronic heart failure. Acta Pharmacol Sin 2017. doi: 10.1038\/aps.2017.167.","journal-title":"Acta Pharmacologica Sinica"},{"key":"103_CR62","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/eci.12785","volume":"47","author":"C Schernthaner","year":"2017","unstructured":"Schernthaner C, Lichtenauer M, Wernly B, Paar V, Pistulli R, Rohm I, et al. Multibiomarker analysis in patients with acute myocardial infarction. Eur J Clin Invest 2017; 47: 638\u201348.","journal-title":"Eur J Clin Invest"},{"key":"103_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000446652","volume":"53","author":"K Chen","year":"2016","unstructured":"Chen K, Chen QJ, Wang LJ, Liu ZH, Zhang Q, Yang K, et al. Increment of HFABP level in coronary artery in-stent restenosis segments in diabetic and nondiabetic minipigs: HFABP overexpression promotes multiple pathway-related inflammation, growth and migration in human vascular smooth muscle cells. J Vasc Res 2016; 53: 27\u201338.","journal-title":"J Vasc Res"},{"key":"103_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF01270583","volume":"116","author":"AH Kleine","year":"1992","unstructured":"Kleine AH, Glatz JF, Van Nieuwenhoven FA, Van der Vusse GJ. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992; 116: 155\u201362.","journal-title":"Mol Cell Biochem"},{"key":"103_CR65","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/clinchem\/43.8.1372","volume":"43","author":"J Ishii","year":"1997","unstructured":"Ishii J, Wang JH, Naruse H, Taga S, Kinoshita M, Kurokawa H, et al. Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction. Clin Chem 1997; 43: 1372\u20138.","journal-title":"Clin Chem"},{"key":"103_CR66","first-page":"BC08","volume":"9","author":"AK Pyati","year":"2015","unstructured":"Pyati AK, Devaranavadagi BB, Sajjannar SL, Nikam SV, Shannawaz M. Sudharani. Heart-type fatty acid binding protein: a better cardiac biomarker than CK-MB and myoglobin in the early diagnosis of acute myocardial infarction. J Clin Diagn Res 2015; 9: BC08\u201311.","journal-title":"J Clin Diagn Res"},{"key":"103_CR67","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ijcard.2011.10.080","volume":"166","author":"Y Kagawa","year":"2013","unstructured":"Kagawa Y, Toyofuku M, Masaoka Y, Muraoka Y, Okimoto T, Otsuka M, et al. Comparison of heart-type fatty acid binding protein and sensitive troponin for the diagnosis of early acute myocardial infarction. Int J Cardiol 2013; 166: 347\u201351.","journal-title":"Int J Cardiol"},{"key":"103_CR68","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.ihj.2015.06.035","volume":"67","author":"A Vupputuri","year":"2015","unstructured":"Vupputuri A, Sekhar S, Krishnan S, Venugopal K, Natarajan KU. Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain. Indian Heart J 2015; 67: 538\u201342.","journal-title":"Indian Heart J"},{"key":"103_CR69","first-page":"315","volume":"66","author":"S Garcia-Valdecasas","year":"2011","unstructured":"Garcia-Valdecasas S, Ruiz-Alvarez MJ, Garcia De Tena J, De Pablo R, Huerta I, Barrionuevo M, et al. Diagnostic and prognostic value of heart-type fatty acid-binding protein in the early hours of acute myocardial infarction. Acta?Cardiol 2011; 66: 315\u201321.","journal-title":"Acta?Cardiol"},{"key":"103_CR70","first-page":"473","volume":"62","author":"M Ozdemir","year":"2007","unstructured":"Ozdemir M, Durakoglugil E, Gulbahar O, Turkoglu S, Sancak B, Pasaoglu H, et al. Heart fatty acid binding protein and myoglobin after reperfusion of acute myocardial infarction. Acta?Cardiol 2007; 62: 473\u20138.","journal-title":"Acta?Cardiol"},{"key":"103_CR71","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0304-4165(91)90148-A","volume":"1073","author":"DK Das","year":"1991","unstructured":"Das DK, Barua PK, Jones RM. Release of fatty acid-binding protein from ischemic-reperfused rat heart and its prevention by mepacrine. Biochim Biophys Acta 1991; 1073: 394\u2013401.","journal-title":"Biochim Biophys Acta"},{"key":"103_CR72","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0009-8981(00)00259-X","volume":"298","author":"JA de Lemos","year":"2000","unstructured":"de Lemos JA, Antman EM, Morrow DA, Llevadot J, Giugliano RP, Coulter SA, et al. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy. Clin Chim Acta 2000; 298: 85\u201397.","journal-title":"Clin Chim Acta"},{"key":"103_CR73","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1253\/jcj.64.18","volume":"64","author":"N Hayashida","year":"2000","unstructured":"Hayashida N, Chihara S, Akasu K, Oda T, Tayama E, Kai E, et al. Plasma and urinary levels of heart fatty acid-binding protein in patients undergoing cardiac surgery. Jpn Circ J 2000; 64: 18\u201322.","journal-title":"Jpn Circ J"},{"key":"103_CR74","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1053\/j.jvca.2009.09.012","volume":"24","author":"GT Wong","year":"2010","unstructured":"Wong GT, Huang Z, Ji S, Irwin MG. Remifentanil reduces the release of biochemical markers of myocardial damage after coronary artery bypass surgery: a randomized trial. J Cardiothorac Vasc Anesth 2010; 24: 790\u20136.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"103_CR75","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1536\/ihj.46.601","volume":"46","author":"M Suzuki","year":"2005","unstructured":"Suzuki M, Hori S, Noma S, Kobayashi K. Prognostic value of a qualitative test for heart-type fatty acid-binding protein in patients with acute coronary syndrome. Int Heart J 2005; 46: 601\u20136.","journal-title":"Int Heart J"},{"key":"103_CR76","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/CIRCULATIONAHA.106.641936","volume":"114","author":"M O'Donoghue","year":"2006","unstructured":"O'Donoghue M, de Lemos JA, Morrow DA, Murphy SA, Buros JL, Cannon CP, et al. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation 2006; 114: 550\u20137.","journal-title":"Circulation"},{"key":"103_CR77","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1373\/clinchem.2004.047662","volume":"51","author":"J Ishii","year":"2005","unstructured":"Ishii J, Ozaki Y, Lu J, Kitagawa F, Kuno T, Nakano T, et al. Prognostic value of serum concentration of heart-type fatty acid-binding protein relative to cardiac troponin T on admission in the early hours of acute coronary syndrome. Clin Chem 2005; 51: 1397\u2013404.","journal-title":"Clin Chem"},{"key":"103_CR78","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1016\/j.jacc.2007.08.021","volume":"50","author":"N Kilcullen","year":"2007","unstructured":"Kilcullen N, Viswanathan K, Das R, Morrell C, Farrin A, Barth JH, et al. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. J Am Coll Cardiol 2007; 50: 2061\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"103_CR79","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1016\/j.jacc.2009.12.062","volume":"55","author":"K Viswanathan","year":"2010","unstructured":"Viswanathan K, Kilcullen N, Morrell C, Thistlethwaite SJ, Sivananthan MU, Hassan TB, et al. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative. J Am Coll Cardiol 2010; 55: 2590\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"103_CR80","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1253\/circj.CJ-12-0999","volume":"77","author":"S Matsumoto","year":"2013","unstructured":"Matsumoto S, Nakatani D, Sakata Y, Suna S, Shimizu M, Usami M, et al. Elevated serum heart-type fatty acid-binding protein in the convalescent stage predicts long-term outcome in patients surviving acute myocardial infarction. Circ J 2013; 77: 1026\u201332.","journal-title":"Circ J"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/aps201837","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/aps201837.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/aps.2018.37","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/aps201837.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:37:37Z","timestamp":1684399057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/aps201837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["103"],"URL":"https:\/\/doi.org\/10.1038\/aps.2018.37","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]},"assertion":[{"value":"5 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}